ORIONS Money Stocks

[Covid19freak]

WAVE.V =MC $8 M /2 MEGA CANCER Drug Approvals IMMINENT in Q4 for the US and European markets . Company has already 5x APPROVED Cancer Drugs for EU markets 2 of them jsut approved in last 2 weeks . This COMPLETE unknown Company is close to profitability . This stock is what i call A ONCE in A LIFETIME OPP guys market cap of C$ 8 million is more than just a PURE GIFT .


Waverley Pharma (WAVE.V) canadian company


Waverley Pharma Announces Grant of Market Authorization of Pemetrexed and Bortezomib in Multiple European Countries.. July 30, 2020
https://www.waverleypharma.com/uploads/3/8/0/2/38024367/waverley_pharma_-_press_release_-_july_30_2020.pdf


Pipeline
https://www.waverleypharma.com/generic-product-pipeline.html

WAV-101 is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other indications. Currently there is no marketed generic version for this product in the United States, and the brand generates yearly revenue of over $1 billion USD. Since regulatory filings have been made in the United States and Europe, Waverley Pharma is seeking a sales and marketing partner for Europe.

WAV-102 is an injectable generic chemotherapy drug developed for the treatment of multiple myeloma and other indications. Currently there is no marketed generic for this product and the brand generates yearly revenue of over $800 million USD. Since regulatory filings have been made in the United States and Europe, Waverley Pharma is seeking a sales and marketing partner for Europe.